During the past decade, Studienzentrum Schwittay conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Studienzentrum Schwittay" #1 collaborator was "ClinStat GmbH" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Studienzentrum Schwittay" are "Gastroparesis" (4 trials), "Diabetes Mellitus" (3 trials), "Chronic Kidney Disease (CKD)" (1 trials) and "Non-valvular Atrial Fibrillation (NVAF)" (1 trials). Many other conditions were trialed in "Studienzentrum Schwittay" in a lesser frequency.

Most popular intervention types in "Studienzentrum Schwittay" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Relamorelin" (3 trials) and "Relamorelin 10 μg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Studienzentrum Schwittay" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Studienzentrum Schwittay". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Studienzentrum Schwittay, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Studienzentrum Schwittay, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".